Vedire, Yeshwanth Reddy
Mukherjee, Sarbajit
Dondapati, Sumedha
Yendamuri, Sai
Funding for this research was provided by:
National Comprehensive Cancer Network,United States
Ipsen Biopharmaceuticals
National Cancer Institute (R01CA255515-01A1)
Article History
Received: 5 October 2022
Accepted: 5 May 2023
First Online: 24 May 2023
Competing interests
: Dr. Sarbajit Mukherjee received research support from the NCCN Oncology research program and Ipsen biopharmaceuticals (paid to the institute). All other authors declare no other potential competing interests.